jemperil 100 mg

Jemperil 100 mg is a sterile, preservative-free, colorless to slightly yellowish solution for infusion. It contains the active substance Atezolizumab, which is a monoclonal antibody (a type of protein) designed to recognize and attach to a specific target in the body called PD-L1.

2. Mechanism of Action:
Jemperil is an immunotherapy drug known as an immune checkpoint inhibitor. It works by binding to a protein called PD-L1 on tumor cells and immune cells. By blocking this protein, Jemperil reactivates the body’s immune system (specifically T-cells) to attack and kill cancer cells.

3. Therapeutic Indications (Uses):
Jemperil is used to treat several types of cancer in adults. Its use may vary by country, but common indications include:

• Lung Cancer: For the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients whose disease progressed during or after chemotherapy, or as a first-line treatment in combination with other therapies.

• Liver Cancer: For the treatment of patients with unresectable or advanced Hepatocellular Carcinoma (HCC) who have not received prior systemic therapy (often in combination with other targeted drugs).

• Breast Cancer: For the treatment of patients with PD-L1-positive, metastatic Triple-Negative Breast Cancer (TNBC) in combination with chemotherapy.

• Bladder Cancer: For the treatment of locally advanced or metastatic Urothelial Carcinoma.

• Melanoma: For the treatment of certain types of melanoma.

4. Warnings and Precautions:
Jemperil can cause serious side effects by triggering an overactive immune response. It is crucial to be aware of the following:

• Immune-Related Reactions: This medication can cause inflammation in healthy organs. Inform your doctor immediately if you experience new or worsening symptoms, including:

  • Lung Problems (Pneumonitis): New or worsening cough, chest pain, shortness of breath.

  • Intestinal Problems (Colitis): Diarrhea, bloody stools, severe stomach pain.

  • Liver Problems (Hepatitis): Yellowing of skin or eyes, severe nausea, dark urine, bleeding.

  • Hormonal Gland Problems (Endocrinopathies): Severe headaches, rapid heartbeat, extreme fatigue, hair loss, weight changes.

  • Kidney Problems: Decreased urine output, blood in urine.

  • Skin Problems: Severe rash, blistering, or peeling skin.

  • Infusion Reactions: Chills, shaking, fever, difficulty breathing during or after the infusion.

• Infections: Jemperil may increase the risk of serious infections.

• Pregnancy and Contraception: Jemperil can harm an unborn baby. Women of childbearing potential must use effective contraception during treatment and for at least 5 months after the last dose. Do not breastfeed while taking this medication.

5. Administration:
Jemperil is administered exclusively by healthcare professionals as an intravenous (IV) infusion over 30–60 minutes, typically every 2, 3, or 4 weeks.

6. Storage:
Store in a refrigerator (2°C to 8°C). Do not freeze. Keep the vial in the outer carton to protect from light.